Differential role of TNF-α and IFN-γ in the brain of rats with chronic relapsing autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 96, Issue 1, 1999, Pages 73-79

  Tanuma, Naoyuki ^a,b   Shin, Taekyun ^a   Kogure, Kazunari ^a   Matsumoto, Yoh ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Competitive PCR; Cytokine; Experimental autoimmune encephalomyelitis; Relapse

Indexed keywords

CYCLOSPORIN A; CYTOKINE; INTERLEUKIN 10; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RELAPSE;

ANIMALS; BRAIN; CHRONIC DISEASE; CYCLOSPORINE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION; GUINEA PIGS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENTRICULAR; INTERFERON TYPE II; INTERLEUKIN-10; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED LEW; RECURRENCE; RNA, MESSENGER; SPINAL CORD; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033119188     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00018-1     Document Type: Article

References (26)

1. Billiau A., Heremans H., Vandekerckhove F., Dijkmans R., Sobis H., Meulepas E., Carton H. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ J. Immunol. 140:1988;1506-1510.
2. Crisi G.M., Santambrogio L., Hochwald G.M., Smith S.R., Carlino J.A., Thorbecke G.J. Staphylococcal enterotoxin B and tumor necrosis factor α-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-β and interleukin-10. Eur. J. Immunol. 25:1995;3035-3040.
3. Duong T.T., Finkelman F.D., Singh B., Strejan G.H. Effect of anti-interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53:1994;101-107.
4. Frei K., Eugster H.-P., Bopst M., Constantinescu C.S., Lavi E., Fontana A. Tumor necrosis factor-α and lymphotoxin-α are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1997;2177-2182.
5. Heremans H., Dijkmans R., Sobis H., Vandekerckhove F., Billiau A. Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide. J. Immunol. 138:1987;4175-4179.
6. Heremans H., Dillen C., Groenen M., Martens E., Billiau A. Chronic relapsing experimental autoimmune encephalomyelitis (CR-EAE) in mice: enhancement by monoclonal antibodies against interferon-γ Eur. J. Immunol. 26:1996;2393-2398.
7. Horwitz M.S., Evans C.F., McGavern D.B., Rodriguez M., Oldstone M.B.A. Primary demyelination in transgenic mice expressing interferon-γ Nat. Med. 3:1997;1037-1041.
8. Johns L.D., Flanders K.C., Ranges G.E., Sriram S. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J. Immunol. 147:1991;1792-1796.
9. Krakowski M., Owens T. Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1996;1641-1646.
10. Kuroda Y., Shimamoto Y. Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 34:1991;159-164.
11. Kuruvilla A.P., Shah R., Hochwald G.M., Liggitt H.D., Palladino M.A., Thorbecke G.J. Protective effect of transforming growth factor-β1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. U.S.A. 88:1991;2918-2921.
12. Liu J., Marino M.W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A.J., Old L., Bernard C.C.A. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4:1998;78-83.
13. Mauritz N.J., Holmdahl R., Jonsson R., van der Meide P.H., Scheynius A., Klareskog L. Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum. 31:1988;1297-1304.
14. Mustafa M., Diener P., Höjeberg B., van der Meide P., Olsson T. T cell immunity and interferon-γ secretion during experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 31:1991;165-177.
15. Nakajima H., Takamori Y., Hiyama Y., Tsukada W. The effect of treatment with interferon-gamma on type II collagen-induced arthritis. Clin. Exp. Immunol. 81:1990;441-445.
16. Panitch H.S., Hirsch R.L., Schindler J., Johnson K.P. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology. 37:1987;1097-1102.
17. Polman C.H., Matthaei I., de Groot C.J.A., Koetsier J.C., Sminia T., Dijkstra C.D. Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat. J. Neuroimmunol. 17:1988;209-216.
18. Racke M.K., Dhib-Jalbut S., Cannella B., Albert P.S., Raine C.S., McFarlin D.E. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J. Immunol. 146:1991;3012-3017.
19. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
20. Segal B.M., Dwyer B.K., Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187:1998;537-546.
21. Selmaj K., Raine C.S., Cross A.H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30:1991;694-700.
22. Selmaj K., Papierz W., Glabinski A., Kohno T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56:1995;135-141.
23. Simmons R.D., Willenborg D.O. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 100:1990;37-42.
24. Tanuma N., Kojima T., Shin T., Aikawa Y., Kohji T., Ishihara Y., Matsumoto Y. Competitive PCR quantification of pro- and anti-inflammatory cytokine mRNA in the central nervous system during autoimmune encephalomyelitis. J. Neuroimmunol. 73:1997;197-206.
25. Voorthuis J.A.C., Uitdehaag B.M.J., de Groot C.J.A., Goege P.H., van der Meide P.H., Dijkstra C.D. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin. Exp. Immunol. 81:1990;183-188.
26. Willenborg D.O., Fordham S., Bernard C.C.A., Cowden W.B., Ramshaw I.A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:1996;3223-3227.